HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantationElizabeth F. Krakow, Marie Bleakley, Kyle B. Woodward et al.|Blood|2024Cited by 29
Ibrutinib Monotherapy in Relapsed or Refractory, Transformed Diffuse Large B-cell LymphomaSolomon A. Graf, Ajay K. Gopal, Ryan D. Cassaday et al.|Clinical Lymphoma Myeloma & Leukemia|2020Cited by 13
Single-Agent Subcutaneous Blinatumomab for Advanced B-Cell Acute Lymphoblastic Leukemia: Long-Term Follow-up from a Phase 1b Dose Expansion CohortElias Jabbour, Hagop M. Kantarjian, Gerhard Zugmaier et al.|Blood|2024Cited by 3